<?xml version="1.0" encoding="UTF-8"?>
<p>Yellow fever (YF) is an acute viral hemorrhagic disease which is currently endemic to ∼50 countries with ∼1 billion people living at risk of infection. Despite the availability of a highly efficient vaccine (YFV-17D; e.g., Stamaril), an estimated ∼0.2 million YFV infections with 29,000 to 60,000 deaths occur annually (
 <xref rid="B5" ref-type="bibr">5</xref>). Recent YFV outbreaks in Angola (2015-2016), the Democratic Republic of the Congo (2016), Brazil (2017), and Nigeria (2018) and a shortage of the YF vaccine supply raised serious concerns about the preparedness for future outbreaks (
 <xref rid="B6" ref-type="bibr">6</xref>, 
 <xref rid="B7" ref-type="bibr">7</xref>). Since the 
 <named-content content-type="genus-species">Aedes aegypti</named-content> mosquito, the main YFV vector, is omnipresent in (sub)tropical Asia, YFV spillover to Asia and the establishment of epidemics involving urban transmission become increasingly realistic (
 <xref rid="B8" ref-type="bibr">8</xref>, 
 <xref rid="B9" ref-type="bibr">9</xref>).
</p>
